Phibro Animal Health (NASDAQ:PAHC) Shares Climb 3.2% - Should You Buy?

Key Points

• Phibro Animal Health shares rose 3.2% to about $37.98, though trading volume was 89% below the average. Analysts’ consensus rating is “Moderate Buy,” with a $47.67 price target.
• The company exceeded quarterly expectations, reporting $0.85 EPS versus the $0.71 estimate and revenue of $396.75 million compared with the $381.18 million consensus.
• Phibro pays a quarterly dividend of $0.12 per share, equivalent to a $0.48 annualized payout and 1.3% yield; institutional investors own 99.34% of the stock.

Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report) was up 3.2% on Wednesday. The company traded as high as $38.10 and last traded at $37.9760. 30,350 shares were traded during mid-day trading, a decline of 89% from the average daily volume of 288,020 shares. The stock had previously closed at $36.81.

Analyst Ratings Changes

Several equities analysts recently issued reports on PAHC shares. Zacks Research raised Phibro Animal Health from a "hold" rating to a "strong-buy" rating in a research note on Friday, September 18th. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Phibro Animal Health in a research report on Friday, September 11th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, Phibro Animal Health has a consensus rating of "Moderate Buy" and a consensus price target of $47.67.

Phibro Animal Health Stock Up 3.1%

The firm has a 50 day moving average price of $36.01 and a 200-day moving average price of $38.73. The company has a current ratio of 2.96, a quick ratio of 1.27 and a debt-to-equity ratio of 1.84. The firm has a market cap of $1.54 billion, a PE ratio of 15.61, a PEG ratio of 1.08 and a beta of 0.42.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its earnings results on Wednesday, August 26th. The company reported $0.85 earnings per share for the quarter, beating the consensus estimate of $0.71 by $0.14. Phibro Animal Health had a net margin of 6.57% and a return on equity of 37.86%. The firm had revenue of $396.75 million for the quarter, compared to analysts' expectations of $381.18 million. Phibro Animal Health has set its FY 2027 guidance at 3.410-3.590 EPS. Research analysts forecast that Phibro Animal Health Corporation will post 3.50 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 23rd. Stockholders of record on Wednesday, September 2nd were given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 1.3%. The ex-dividend date of this dividend was Wednesday, September 2nd. Phibro Animal Health's payout ratio is 19.67%.

Hedge Funds Weigh In On Phibro Animal Health

Several large investors have recently bought and sold shares of PAHC. Engineers Gate Manager LP lifted its holdings in Phibro Animal Health by 112.8% during the 2nd quarter. Engineers Gate Manager LP now owns 52,914 shares of the company's stock worth $1,662,000 after buying an additional 28,052 shares during the last quarter. Baird Financial Group Inc. boosted its position in shares of Phibro Animal Health by 2.7% during the 2nd quarter. Baird Financial Group Inc. now owns 10,710 shares of the company's stock worth $336,000 after acquiring an additional 279 shares in the last quarter. Ranger Investment Management L.P. purchased a new position in Phibro Animal Health in the second quarter valued at approximately $9,182,000. Globeflex Capital L P acquired a new stake in Phibro Animal Health during the second quarter worth approximately $5,942,000. Finally, Bank of America Corp DE lifted its position in shares of Phibro Animal Health by 22.6% during the 1st quarter. Bank of America Corp DE now owns 78,957 shares of the company's stock worth $4,367,000 after buying an additional 14,536 shares during the last quarter. Hedge funds and other institutional investors own 99.34% of the company's stock.

About Phibro Animal Health

Phibro Animal Health Corporation NASDAQ: PAHC develops, manufactures and distributes products that support animal health, nutrition and performance. The company serves livestock producers, veterinarians, feed manufacturers and other customers across the food-animal and companion-animal markets.

Its portfolio includes animal health products such as vaccines, medicated feed additives and other solutions used to help prevent and manage disease. Phibro also provides mineral nutrition products, feed additives and performance solutions designed to support animal growth, feed efficiency, health and productivity.

Phibro Animal Health traces its roots to 1916 and operates internationally, serving customers in the United States and markets around the world.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.